GLP-1s have reshaped obesity treatment and healthcare in 2023. What's next in 2024? Accolade's report unpacks trends, costs, and HR insights to help guide employers toward understanding their role in the care continuum of treating obesity
In 2023, GLP-1 medications have stormed the healthcare scene as a treatment for obesity. But what does 2024 hold? Our report dives into the shifting attitudes of benefits planners towards these treatments. Discover key insights from HR decision-makers, explore cost implications, and understand the rising demand for trusted information.
Are you prepared to optimize your benefits package for an increasingly health-conscious world? Get ahead with Accolade’s comprehensive employee health trends report.
Discover how healthier employees can lead to smarter savings. Accolade transforms healthcare for businesses, reducing costs while improving productivity and outcomes. Learn how you can build a thriving workforce today...
View nowAs healthcare expenses escalate, employers seek ways to lower their costs. Some reduce benefits or increase employee contributions. However, progressive employers add a benefit that decreases costs and improves experiences: second opinion solutions...
View nowA large part of lost productivity happens when people are at work, but not fully functioning. Yet, if an employee makes an appointment the day their pain begins, it can take 26 days to see a doctor. That may leave them suffering and listless for weeks...
View now
